Literature DB >> 2405791

The bacteriology of gangrenous and perforated appendicitis--revisited.

R S Bennion1, E J Baron, J E Thompson, J Downes, P Summanen, D A Talan, S M Finegold.   

Abstract

By using optimum sampling, transport, and culture techniques in patients with gangrenous or perforated appendicitis, we recovered than has previously been reported. Thirty patients older than 12 years with histologically documented gangrenous or perforated appendicitis had peritoneal fluid, appendiceal tissue, and abscess contents (if present) cultured. Appendiceal tissue was obtained so as to exclude the lumen. A total of 223 anaerobes and 82 aerobic or faculatative bacteria were recovered, an average of 10.2 different organisms per specimen. Twenty-one different genera and more than 40 species were encountered. Bacteroides fragilis group and Escherichia coli were isolated from almost all specimens. Within the B. fragilis group, eight species were represented. Other frequent isolates included Peptostreptococcus (80%), Pseudomonas (40% [P. aeruginosa, 23.3%, other Pseudomonas spp., 16.7%]), B. splanchnicus (40%), B. intermedius (36.7%), and Lactobacillus (36.7%). Interestingly a previously undescribed fastidious gram-negative anaerobic bacillus was isolated from nearly one half of all patients. This organism was found to have low DNA homology (by dot blot) with the known organisms most closely resembling it.

Entities:  

Mesh:

Year:  1990        PMID: 2405791      PMCID: PMC1357960          DOI: 10.1097/00000658-199002000-00008

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  17 in total

1.  THE BACTERIAL FLORA OF ACUTE PERFORATED APPENDICITIS WITH PERITONITIS: A BACTERIOLOGIC STUDY BASED UPON ONE HUNDRED CASES.

Authors:  W A Altemeier
Journal:  Ann Surg       Date:  1938-04       Impact factor: 12.969

2.  The Relation of the Welch Bacillus to Appendicitis and its Complications.

Authors:  J E Jennings
Journal:  Ann Surg       Date:  1931-04       Impact factor: 12.969

3.  Surgically treated gangrenous or perforated appendicitis. A comparison of aztreonam and clindamycin versus gentamicin and clindamycin.

Authors:  T V Berne; A E Yellin; M D Appleman; M A Gill; F C Chenella; P N Heseltine
Journal:  Ann Surg       Date:  1987-02       Impact factor: 12.969

4.  Beta-haemolytic streptococci in acute appendicitis. An ominous finding?

Authors:  J Jakobsen; J C Andersen; I C Klausen
Journal:  Acta Chir Scand       Date:  1988-04

5.  The role of gastrointestinal microflora in the pathogenesis of complications of mesenteric ischemia.

Authors:  R S Bennion; S E Wilson; A I Serota; R A Williams
Journal:  Rev Infect Dis       Date:  1984 Mar-Apr

6.  Bacterial studies of peritoneal cavity and postoperative surgical wound drainage following perforated appendix in children.

Authors:  I Brook
Journal:  Ann Surg       Date:  1980-08       Impact factor: 12.969

7.  The bacteriology and septic complication of patients with appendicitis.

Authors:  W Y Lau; C H Teoh-Chan; S T Fan; W C Yam; K F Lau; S H Wong
Journal:  Ann Surg       Date:  1984-11       Impact factor: 12.969

8.  Bacteroides fragilis is a silent pathogen in acute appendicitis.

Authors:  K M Elhag; M H Alwan; M S Al-Adnani; R A Sherif
Journal:  J Med Microbiol       Date:  1986-05       Impact factor: 2.472

9.  Early appendectomy for perforated appendicitis in children should not be abandoned.

Authors:  R S Bennion; J E Thompson
Journal:  Surg Gynecol Obstet       Date:  1987-08

10.  The role of Bacteroides fragilis in the pathogenesis of acute appendicitis.

Authors:  R Pieper; L Kager; A Weintraub; A A Lindberg; C E Nord
Journal:  Acta Chir Scand       Date:  1982
View more
  44 in total

1.  In vitro activities of MK-826 (L-749,345) against 363 strains of anaerobic bacteria.

Authors:  H M Wexler; D Molitoris; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

2.  Comparative In vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infections.

Authors:  E J Goldstein; D M Citron; C Vreni Merriam; Y Warren; K L Tyrrell
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

3.  Comparison of effects of medium composition and atmospheric conditions on detection of Bilophila wadsworthia beta-lactamase by cefinase and cefinase plus methods.

Authors:  P H Summanen
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  Sydney M. Finegold.

Authors: 
Journal:  J Clin Microbiol       Date:  2012-05-23       Impact factor: 5.948

5.  Concurrent presentation of appendicitis and acute cholecystitis: diagnosis of rare occurrence.

Authors:  Jamish Gandhi; Jeffrey Tan
Journal:  BMJ Case Rep       Date:  2015-09-22

6.  Bilophila wadsworthia isolates from clinical specimens.

Authors:  E J Baron; M Curren; G Henderson; H Jousimies-Somer; K Lee; K Lechowitz; C A Strong; P Summanen; K Tunér; S M Finegold
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

7.  Antimicrobial susceptibility testing of Bilophila wadsworthia isolates submitted for routine laboratory examination.

Authors:  C Mochida; Y Hirakata; J Matsuda; F Iori; Y Ozaki; M Nakano; K Hamaguchi; K Izumikawa; T Yamaguchi; K Tomono; S Maesaki; Y Yamada; S Kohno; S Kamihira
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

8.  Efficient electrotransformation of Bacteroides fragilis.

Authors:  Minoru Ichimura; Haruyuki Nakayama-Imaohji; Shin Wakimoto; Hidetoshi Morita; Tetsuya Hayashi; Tomomi Kuwahara
Journal:  Appl Environ Microbiol       Date:  2010-03-26       Impact factor: 4.792

Review 9.  Primary and secondary peritonitis: an update.

Authors:  M Laroche; G Harding
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 3.267

10.  Morphological response of Bilophila wadsworthia to imipenem: correlation with properties of penicillin-binding proteins.

Authors:  P Summanen; H M Wexler; K Lee; S A Becker; M M Garcia; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.